Concepedia

Joshua G. Liang

JG

10

Publications

763

Citations

10

H-Index

2016

Active since

Affiliations

Clover Biopharmaceuticals (China)(Current)

Princess Margaret Hospital for Children

The Kids Research Institute Australia

The University of Western Australia

Public Health Clinical Center of Chengdu

Joshua G. Liang is an author at Clover Biopharmaceuticals (China) specializing in medicine, vaccination, and immunology.

Top concepts

Publications per year

2016–2022

10

Publications

10

Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial

Peter Richmond, Lara Hatchuel, Min Dong et al. · The Lancet · 2021 · 279 citations · Full text

S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates

Joshua G. Liang, Danmei Su, Tian‐Zhang Song et al. · Nature Communications · 2021 · 160 citations · Full text

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial

Lulu Bravo, Igor Smolenov, Htay Htay Han et al. · The Lancet · 2022 · 112 citations · Full text

, , +9

Improvement of Pharmacokinetic Profile of TRAIL via Trimer-Tag Enhances its Antitumor Activity in vivo

Haipeng Liu, Danmei Su, Jinlong Zhang et al. · Scientific Reports · 2017 · 90 citations · Full text

S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates

Joshua G. Liang, Danmei Su, Tian‐Zhang Song et al. · 2020 · 26 citations · Full text

, , +14

Rows per page

1–5 of 10